Cargando…

Single-cell landscape of immune cells in human livers affected by HBV-related cirrhosis

BACKGROUND & AIMS: HBV infection is one of the leading causes of liver cirrhosis. However, the immune microenvironment in patients with HBV cirrhosis remains elusive. METHODS: Single-cell RNA sequencing was used to analyse the transcriptomes of 76,210 immune cells in the livers of six healthy in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Qingquan, Hong, Xiaoting, Lin, Han, He, Xiao, Li, Runyang, Hassan, Mohsin, Berger, Hilmar, Tacke, Frank, Engelmann, Cornelius, Hu, Tianhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582775/ https://www.ncbi.nlm.nih.gov/pubmed/37860052 http://dx.doi.org/10.1016/j.jhepr.2023.100883

Ejemplares similares

The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease
por: Engelmann, Cornelius, et al.
Publicado: (2022)

Pulmonary Complications in Patients with Liver Cirrhosis
por: Benz, Fabian, et al.
Publicado: (2020)

Factors affecting the outcome of hospitalization among liver cirrhosis patients
por: Irfan, Muhammad, et al.
Publicado: (2019)

Red cell distribution width-to-lymphocyte ratio: A novel predictor for HBV-related liver cirrhosis
por: Zhang, Xueyan, et al.
Publicado: (2020)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Changes in intestinal microbiota of HBV-associated liver cirrhosis with/without hepatic encephalopathy
por: Hua, Xiaoli, et al.
Publicado: (2022)

Apparent Diffusion Coefficient Is a Novel Imaging Biomarker of Myopathic Changes in Liver Cirrhosis
por: Surov, Alexey, et al.
Publicado: (2018)

Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis
por: Xia, Xiaoxue, et al.
Publicado: (2018)

Use of Human Albumin Administration for the Prevention and Treatment of Hyponatremia in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis
por: Bai, Zhaohui, et al.
Publicado: (2022)

Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis
por: Jia, Yifan, et al.
Publicado: (2020)

The impact of recipient age on the effects of umbilical cord mesenchymal stem cells on HBV-related acute-on-chronic liver failure and liver cirrhosis
por: Zhang, Ka, et al.
Publicado: (2021)

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation
por: Yuan, Lunzhi, et al.
Publicado: (2019)

Serum C-reactive protein predicts early mortality in hospitalized patients with HBV-related decompensated cirrhosis
por: Zhu, ShaoMing, et al.
Publicado: (2017)

Therapeutic effect of autologous bone marrow cells injected into the liver under the guidance of B‑ultrasound in the treatment of HBV‑related decompensated liver cirrhosis
por: Li, Lei, et al.
Publicado: (2022)

An MLP Classifier for Prediction of HBV-Induced Liver Cirrhosis Using Routinely Available Clinical Parameters
por: Cao, Yuan, et al.
Publicado: (2013)

Association between liver cirrhosis and estimated glomerular filtration rates in patients with chronic HBV infection
por: Wang, Dexin, et al.
Publicado: (2020)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

Transient portal vein thrombosis in liver cirrhosis
por: Qi, Xingshun, et al.
Publicado: (2018)

Hepatitis B Vaccination in Patients with Liver Cirrhosis Evaluated for Liver Transplantation – A Simple Intervention Ensures High Adherence
por: Herta, Toni, et al.
Publicado: (2019)

Risk factors associated with hepatic osteopathy in HBV related cirrhosis measured by liver stiffness: An Observational study
por: Zhang, Wei, et al.
Publicado: (2019)

Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis
por: Wang, Tongyu, et al.
Publicado: (2022)

Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns
por: Juanola, Oriol, et al.
Publicado: (2021)

Immunologic Characterization of Posthepatitis Cirrhosis Caused by HBV and HCV Infection
por: Li, Wan-Yu, et al.
Publicado: (2010)

Serum potassium levels and prognosis in HBV‐associated decompensated cirrhosis
por: Huang, JianJiang, et al.
Publicado: (2021)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
por: Chen, Xiongfei, et al.
Publicado: (2020)

Liver Cell Transformation in Chronic HBV Infection
por: Benhenda, Shirine, et al.
Publicado: (2009)

From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
por: Mohr, Raphael, et al.
Publicado: (2021)

Molecular quantification and differentiation of Candida species in biological specimens of patients with liver cirrhosis
por: Krohn, Sandra, et al.
Publicado: (2018)

Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis
por: Becker, Susen, et al.
Publicado: (2017)

Anti-Hepatitis B Virus X Protein in Sera Is One of the Markers of Development of Liver Cirrhosis and Liver Cancer Mediated by HBV
por: Zhang, Hang, et al.
Publicado: (2009)

Reduced Energy Metabolism Impairs T Cell-Dependent B Cell Responses in Patients With Advanced HBV-Related Cirrhosis
por: Huang, Chunhong, et al.
Publicado: (2021)

FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
por: Lu, Xiao-Jie, et al.
Publicado: (2020)

HBV-related acute-on-chronic liver failure with underlying chronic hepatitis has superior survival compared to cirrhosis
por: Liu, Xiaohui, et al.
Publicado: (2021)

Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study
por: Essa, Abdallah, et al.
Publicado: (2023)

Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer
por: Lurje, Isabella, et al.
Publicado: (2020)

The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial
por: Casper, Markus, et al.
Publicado: (2015)

Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2019)

Prognostic value of albumin‐related ratios in HBV‐associated decompensated cirrhosis
por: Zhang, Tan, et al.
Publicado: (2022)

HBV-Specific CD8+ T-Cell Tolerance in the Liver
por: Baudi, Ian, et al.
Publicado: (2021)

Resolving the fibrotic niche of human liver cirrhosis at single cell level
por: Ramachandran, P, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h0njs22gigco8und91ig39c9qe